Pharmaceutical combination against obesity or excess weight

New pharmaceutical compositions or products which, together with suitable excipients, comprise as active agents therapeutically effective quantities of: a) one or more beta-3-adrenergic agonists, particularly 4-[2-[2- hydroxy-2-(3-chlorophenyl)ethylamino]propyl]phenoxyacetic acid (BRL 37344), the me...

Full description

Saved in:
Bibliographic Details
Main Authors ALEMANY LAMANA MARIANO, MONSERRAT VIDAL CARLOS
Format Patent
LanguageEnglish
Spanish
Published 16.01.1997
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:New pharmaceutical compositions or products which, together with suitable excipients, comprise as active agents therapeutically effective quantities of: a) one or more beta-3-adrenergic agonists, particularly 4-[2-[2- hydroxy-2-(3-chlorophenyl)ethylamino]propyl]phenoxyacetic acid (BRL 37344), the methyl ester thereof (BRL 35135) or the hydrobromide of the latter (BRL 35135A); and b) one or more substances with antiglucocorticoid effect, in particular a steroid hormone, such as dehydroepiandrosterone, and an inhibitor of the adrenal synthesis of glucocorticoids, such as metyrapone, in combination for simultaneous, separate or successive administration. They preferably comprise in addition: a phosphodiesterase inhibitor, such as caffeine; a prostaglandin synthesis inhibitor, such as aspirin; small quantities of chromium (III), zinc, manganese and selenium salts; and aldosterone. They are useful for the treatment of obesity or excess weight. NUEVAS COMPOSICIONES O PRODUCTOS FARMACEUTICOS QUE, JUNTO CON EXCIPIENTES ADECUADOS, COMPRENDEN COMO AGENTES ACTIVOS CANTIDADES TERAPEUTICAMENTE EFECTIVAS DE: A) UNA O VARIAS SUBSTANCIAS AGONISTAS BETA-3 ADRENERGICAS, PARTICULARMENTE EL ACTIDO 4-[2-[2-HIDROXI-2- (3-CLOROFENIL) ETILAMINO]PROPIL] FENOXIACETICO (BRL 37344), SU ESTER METILICO (BRL 35135), O EL HIDROBROMURO DE ESTE (BRL 35135A); Y B) UNA O VARIAS SUBSTANCIAS CON EFECTO ANTIGLUCOCORTICOIDE, EN PARTICULAR UNA HORMONA ESTEROIDE, COMO LA DESHIDROEPIANDROSTERONA, Y UN INHIBIDOR DE LA SINTESIS ADRENAL DE GLUCOCORTICOIDES, COMO LA METIRAPONA; EN COMBINACION PARA SU ADMINISTRACION SIMULTANEA, SEPARADA O SUCESIVA. PREFERIBLEMENTE COMPRENDEN ADEMAS: UN INHIBIDOR DE LA ACTIVIDAD FOSFODIESTERASICA, COMO LA CAFEINA; UN INHIBIDOR DE LA SINTESIS DE PROSTAGLANDINAS, COMO LA ASPIRINA; PEQUE¥AS CANTIDADES DE SALES DE CROMO (III), ZINC, MANGANESO Y SELENIO; Y ALDOSTERONA. SON UTILES PARA EL TRATAMIENTO DE LA OBESIDAD O EL SOBREPESO.
Bibliography:Application Number: ES19940001714